Clinical impact of complete atrioventricular block in patients with ST-segment elevation myocardial infarction.


Journal

Clinical cardiology
ISSN: 1932-8737
Titre abrégé: Clin Cardiol
Pays: United States
ID NLM: 7903272

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 25 08 2020
revised: 25 10 2020
accepted: 02 11 2020
pubmed: 13 11 2020
medline: 18 8 2021
entrez: 12 11 2020
Statut: ppublish

Résumé

Complete atrioventricular block (CAVB) is a common complication of ST-segment elevation myocardial infarction (STEMI). Although STEMI patients complicated with CAVB had a higher mortality in the thrombolytic era, little is known about the impact of CAVB on STEMI patients who underwent primary percutaneous coronary intervention (PCI). The study aimed at evaluating the clinical impact of CAVB on STEMI patients in the primary PCI era. We consecutively enrolled 1295 STEMI patients undergoing primary PCI within 24 hours from onset. Patients were divided into two groups according to the infarct location: anterior STEMI (n = 640) and nonanterior STEMI (n = 655). The outcomes were all-cause death and major adverse cardiocerebrovascular events (MACCE) with a median follow-up period of 3.8 (1.7-6.6) years. Eighty-one patients (6.3%) developed CAVB. The incidence of CAVB was lower in anterior STEMI patients than in nonanterior STEMI (1.7% vs 10.7%, p < .05). Anterior STEMI patients with CAVB had a higher incidence of all-cause deaths (82% vs 20%, p < .05) and MACCE (82% vs 25%, p < .05) than those without CAVB. Although higher incidence of all-cause deaths was found more in nonanterior STEMI patients with CAVB compared with those without CAVB (30% vs 18%, p < .05), there was no significant difference in the incidence of MACCE (24% vs 19%). Multivariate analysis showed that CAVB was an independent predictor for all-cause mortality and MACCE in anterior STEMI patients, but not in nonanterior STEMI. CAVB is rare in anterior STEMI patients, but remains a poor prognostic complication even in the primary PCI era.

Identifiants

pubmed: 33179796
doi: 10.1002/clc.23510
pmc: PMC7803372
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-99

Informations de copyright

© 2020 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.

Références

Eur Heart J. 2015 Apr 21;36(16):976-83
pubmed: 25205530
Isr Med Assoc J. 2015 May;17(5):298-301
pubmed: 26137656
Clin Cardiol. 2021 Jan;44(1):91-99
pubmed: 33179796
Circulation. 1970 Nov;42(5):925-33
pubmed: 5477260
Am Heart J. 2016 Jan;171(1):25-32
pubmed: 26699597
Am J Cardiol. 1997 Nov 1;80(9):1134-8
pubmed: 9359538
Am Heart J. 2003 Mar;145(3):500-7
pubmed: 12660674
Clin Cardiol. 2009 May;32(5):274-7
pubmed: 19452487
Circulation. 1968 Nov;38(5):987-92
pubmed: 5697695
Clin Cardiol. 1993 Jul;16(7):565-9
pubmed: 8348766
Am Heart J. 2008 Aug;156(2):227-33
pubmed: 18657650
Pacing Clin Electrophysiol. 1998 Dec;21(12):2651-63
pubmed: 9894656
Int J Cardiol. 2013 Oct 9;168(4):3683-90
pubmed: 23838593
Circ Res. 1964 Mar;14:202-11
pubmed: 14133946
Am J Cardiol. 2003 Oct 1;92(7):853-6
pubmed: 14516893
Eur Heart J Acute Cardiovasc Care. 2018 Apr;7(3):218-223
pubmed: 28617040
Lancet. 2003 Jan 4;361(9351):13-20
pubmed: 12517460
J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):32-7
pubmed: 20929008
Am J Cardiol. 2014 Dec 1;114(11):1658-62
pubmed: 25304975
Europace. 2012 Nov;14(11):1639-45
pubmed: 22645234
Am J Cardiol. 1992 May 1;69(14):1135-41
pubmed: 1575181
J Am Coll Cardiol. 1984 Jul;4(1):35-8
pubmed: 6736451
Arq Bras Cardiol. 2009 May;92(5):314-9, 330-5, 342-8
pubmed: 19629284
N Engl J Med. 1993 Sep 2;329(10):673-82
pubmed: 8204123
Circulation. 1965 Dec;32(6):1020-33
pubmed: 5846099
Am J Cardiol. 1991 Feb 1;67(4):225-30
pubmed: 1899319
Circulation. 1978 Oct;58(4):679-88
pubmed: 688579
J Am Coll Cardiol. 1992 Sep;20(3):533-40
pubmed: 1512330
Am Heart J. 2005 Apr;149(4):670-4
pubmed: 15990751
Mayo Clin Proc. 1972 Aug;47(8):562-6
pubmed: 5049161
Am Heart J. 2001 Jan;141(1):47-54
pubmed: 11136486
Am J Pathol. 1962 Jul;41:65-75
pubmed: 14467326
Korean Circ J. 2016 May;46(3):315-23
pubmed: 27275168
J Am Coll Cardiol. 1999 Nov 15;34(6):1721-8
pubmed: 10577562

Auteurs

Yosuke Kawamura (Y)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Hiroaki Yokoyama (H)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Kazutaka Kitayama (K)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Naotake Miura (N)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Misato Hamadate (M)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Daiki Nagawa (D)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Masashi Nozaka (M)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Masamichi Nakata (M)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Fumie Nishizaki (F)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Kenji Hanada (K)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Takashi Yokota (T)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Masahiro Yamada (M)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Takumi Higuma (T)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.

Hirofumi Tomita (H)

Department of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH